galactose has been researched along with Myelodysplastic Syndromes in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ader, F; Aguado, JM; Akova, M; Arendrup, MC; Arikan-Akdagli, S; Barnes, RA; Beigelman-Aubry, C; Blot, S; Bouza, E; Brüggemann, RJM; Buchheidt, D; Cadranel, J; Castagnola, E; Chakrabarti, A; Cornely, OA; Cuenca-Estrella, M; Denning, DW; Dimopoulos, G; Fortun, J; Gangneux, JP; Garbino, J; Groll, AH; Heinz, WJ; Herbrecht, R; Heussel, CP; Kibbler, CC; Klimko, N; Kullberg, BJ; Lagrou, K; Lange, C; Lass-Flörl, C; Lehrnbecher, T; Lewis, RE; Löffler, J; Lortholary, O; Maertens, J; Marchetti, O; Meis, JF; Munoz, P; Pagano, L; Ribaud, P; Richardson, M; Roilides, E; Ruhnke, M; Sanguinetti, M; Sheppard, DC; Sinkó, J; Skiada, A; Ullmann, AJ; Vehreschild, MJGT; Verweij, PE; Viscoli, C; Warris, A | 1 |
| Aguado, JM; Barba, P; Batlle, M; Cuenca-Estrella, M; Fernández-Ruiz, M; Gallardo, D; Heras, I; López-Jiménez, J; Olave, T; Parody, R; Polo, M; Rovira, M; Ruiz-Camps, I; Silva, JT; Solano, C; Vallejo, C; Varela, R; Vázquez, L; Villaescusa, T | 1 |
| Choi, JH; Choi, SM; Kim, CC; Lee, DG; Min, WS; Shin, WS; Yoo, JH | 1 |
1 trial(s) available for galactose and Myelodysplastic Syndromes
| Article | Year |
|---|---|
Serum galactomannan versus a combination of galactomannan and polymerase chain reaction-based Aspergillus DNA detection for early therapy of invasive aspergillosis in high-risk hematological patients: a randomized controlled trial.
Topics: Adult; Aged; Aspergillosis; Aspergillus; DNA, Fungal; Female; Galactose; Humans; Leukemia, Myeloid, Acute; Male; Mannans; Middle Aged; Myelodysplastic Syndromes; Real-Time Polymerase Chain Reaction; Secondary Prevention | 2015 |
2 other study(ies) available for galactose and Myelodysplastic Syndromes
| Article | Year |
|---|---|
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.
Topics: Antibodies, Fungal; Antifungal Agents; Aspergillosis; Aspergillus; Biopsy; Bronchoalveolar Lavage; Disease Management; Early Diagnosis; Flucytosine; Galactose; Humans; Immunocompromised Host; Immunologic Tests; Invasive Pulmonary Aspergillosis; Itraconazole; Leukemia, Myeloid, Acute; Magnetic Resonance Imaging; Mannans; Microbial Sensitivity Tests; Myelodysplastic Syndromes; Nitriles; Pyridines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2018 |
Application of nucleic acid sequence-based amplification for diagnosis of and monitoring the clinical course of invasive aspergillosis in patients with hematologic diseases.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Female; Galactose; Hematologic Diseases; Humans; Immunoenzyme Techniques; Leukemia, Myeloid, Acute; Lung Diseases, Fungal; Male; Mannans; Middle Aged; Myelodysplastic Syndromes; Nucleic Acid Amplification Techniques; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sensitivity and Specificity | 2005 |